Objective: This study aimed to explore the association between GPIa, COX-2 gene polymorphisms and aspirin resistance in the ischemic stroke patients from the southern part of Jiangsu province.
| INTRODUCTION
Stroke is one of the leading causes of human mortality and disability. 1 Early neurologic exercise and recurrent ischemic stroke (IS) are common and are associated with poor prognosis in acute IS patients.
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Antiplatelet drugs, statins, and anti-hypertensive drugs are the third cornerstone of stroke prevention. As a routine therapeutic agent, aspirin is prescribed widely for the prophylaxis of cardio-thrombotic events. The effect of aspirin is achieved by suppressing thromboxane production and further by inhibiting platelet activation and aggregation. 3 Substantial number of patients on aspirin therapy fails to reach this desired effect, and then they experience major adverse vascular events, a phenomenon known as aspirin resistance (AR). 4 Since the discovery of this phenomenon, to unravel the mechanisms of aspirin insensitivity so far remains a daunting task. Evidence is mounting suggests that a strong genetic component underlies aspirin insensitivity.
5,
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
diseases, cancer, severe liver, and kidney dysfunction or autoimmune diseases; (ii) nearly a week to use other antiplatelet drugs or anticoagulant drugs, taking nonsteroidal antiphlogistic drug; (iii) recent trauma or surgery history; and (iv) platelet count <100 × 10 9 /L or >450 × 10 9 /L.
| Platelet aggregation test
Venous blood (5 mL) was drawn from each patient's antecubital veins before and after 7 days of aspirin treatment. Platelet aggregation was measured by PL-11 platelet analyzer (Nanjing British
Novartis Medical Technology Co., Ltd., Nanjing, China). The maximal platelet aggregation rate (MAR) was calculated using arachidonic acid (AA) as an inducer, and MAR ≥ 33.3% was defined as biochemical AR. Otherwise, patients were considered aspirin sensitive (AS).
| Genotyping (Gene single nucleotide polymorphisms detection)
Genomic DNA was isolated from whole blood using the QIAamp Sequencing of the PCR products was carried out using a pyrophosphoric acid sequencer (Qiagen PyroMark Q24, Qi Jiagen Enterprise Management Co., Ltd., Shanghai, China), and the results were directly analyzed by the machine. 
| Statistical analysis

| RESULTS
| AS and AR patients between the general data comparison
Pertinent clinical characteristics of the study population are shown in and AR group has 43 cases (44.3%). There were no significant differences in age, TC, LDL, Lp-PLA2, CRP, and PLT between the two groups (P > .05). There was no significant difference between the two groups in the clinical data of AS and AR patients. Table 2) .
| Association of GPIa gene 807C> T polymorphism with AR
The relationship between biochemical AR and GPIa gene polymorphism was studied after chi-square analysis by sex. In male patients, there were no significant differences in the distribution of the three genotypes in AS and AR groups (P = .930). In female patients, the distribution of CC, CT, and TT genotypes in the two groups was statistically significant different (P < .05) ( Table 3 ).
There were significant differences between the AS and AR groups in the 807C>T locus dominant model and the recessive model in female patients (P < .05). We further corrected the risk factors of AR 
| DISCUSSION
Most of the ischemic strokes are caused by unstable atherosclerotic plaque rupture, leading to thrombosis, and thus the blood vessels of the brain tissue ischemic necrosis. Platelet adhesion, activation is the initiation of thrombosis. The platelet surface GPIa/IIa complex, as the collagen initial receptor, plays an important role in the platelet and damaged vascular wall adhesion and aggregation process. In recent years, it has been found that the two-linked single nucleotide polymorphisms of the C807T (rsl126643) and G873A alleles are associated with the density of GPIa/IIa receptors on the platelet membrane surface in the platelet membrane GPIa gene coding sequence. 17 Therefore, it is speculated that the GPIa gene polymorphism of platelet membrane may be a genetic predisposing factor of thrombotic disease. In this study, the results of χ2 stratification test showed that the differences among the three genotypes were statistically significant in female patients. Due to the small number of TT genotypes, in this paper, χ2 test was performed on the distribution of genotype T A B L E 3 Distribution of GPIa gene polymorphism by gender in both groups used to calibrate the age, hyperlipidemia, low-density lipoprotein, hypertension, and diabetes mellitus. Genotype (CT + TT) was still associated with AR, suggesting that it might be an independent risk factor for biochemical AR. The frequency of T allele in AR group was higher than that in AS group, the difference was statistically significant, suggesting that carrying 807T allele in women increased the incidence of biochemical AR. Studies have found that the expression of the 807T
allele increased the level of cholesterol from atherosclerosis. 18 In this study, genotype CT + TT/CC grouping, compared between the two groups of total cholesterol, low-density lipoprotein, blood glucose, uric acid, and other related factors, no significant differences were found, and the mechanism need for further study. In this study, female patients were aged between 40 and 86 years old, and only two patients <50 years old, the rest were all menopausal women, these maybe one reason why women are more prone to AR. Indication that women carry 807T allele were more prone to AR. Studies have
shown that carrying the 807 T allele increased the risk of stroke in young women, suggesting that genetic factors affect cerebrovascular disease. 19 These suggest that some of the reasons why our findings regarding the association of platelet GPIa/IIa gene polymorphisms with AR are partly due to the demographic characteristics of the study population, and that genetic gene polymorphisms affecting young women or menopausal women may be more significant, so stratification of the population is particularly important. In this study, no single nucleotide polymorphisms at -765G> C were found to be associated with AR.
There are some shortcomings and limitations in this study. First, this study is a single-center retrospective study, some important information is difficult to collect completely; thus, the analysis of variables is not comprehensive, such as smoking, drinking, obesity, and other risk factors were not included, and the amount of samples collected is small. Furthermore, aspirin antiplatelet is involved in a variety of enzymes and receptors in the process, each enzyme and receptor gene has multiple loci polymorphism, and gene-gene and gene-environment differences may affect the results. Therefore, it is necessary to carry out a large sample size, multiple gene loci, multi-factor, multicenter study, to further clarify the pathogenesis of aspirin resistance in patients with cerebral infarction, and to provide the basis for clinical individualization for stroke primary and secondary prevention. T A B L E 5 Distribution of COX-2 gene-765G> C polymorphism in AS and AR groups
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